Stephens Initiates Coverage on Definitive Healthcare (NASDAQ:DH)

Equities researchers at Stephens started coverage on shares of Definitive Healthcare (NASDAQ:DH) in a report released on Friday,Briefing.com Automated Import reports. The firm set an “equal weight” rating and a $5.00 price target on the stock. Stephens’ price objective suggests a potential upside of 20.77% from the stock’s previous close.

Several other equities research analysts have also recently weighed in on the company. Needham & Company LLC reiterated a “hold” rating on shares of Definitive Healthcare in a research report on Friday, November 8th. BTIG Research initiated coverage on Definitive Healthcare in a research note on Tuesday, September 17th. They set a “buy” rating and a $7.00 price objective for the company. One research analyst has rated the stock with a sell rating, eight have given a hold rating and three have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $5.72.

Definitive Healthcare Stock Down 4.6 %

DH stock opened at $4.14 on Friday. The stock has a 50-day simple moving average of $4.42 and a two-hundred day simple moving average of $4.70. The firm has a market capitalization of $478.27 million, a PE ratio of -1.34, a PEG ratio of 3.29 and a beta of 1.40. Definitive Healthcare has a twelve month low of $3.19 and a twelve month high of $10.62. The company has a quick ratio of 2.49, a current ratio of 2.49 and a debt-to-equity ratio of 0.33.

Insider Transactions at Definitive Healthcare

In other news, insider William Moschella sold 45,000 shares of the business’s stock in a transaction on Tuesday, December 3rd. The stock was sold at an average price of $4.70, for a total value of $211,500.00. Following the completion of the transaction, the insider now directly owns 433,830 shares of the company’s stock, valued at approximately $2,039,001. The trade was a 9.40 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Corporate insiders own 14.84% of the company’s stock.

Institutional Trading of Definitive Healthcare

Several hedge funds and other institutional investors have recently bought and sold shares of DH. Massachusetts Financial Services Co. MA grew its holdings in Definitive Healthcare by 36.8% in the third quarter. Massachusetts Financial Services Co. MA now owns 6,053,233 shares of the company’s stock valued at $27,058,000 after purchasing an additional 1,626,813 shares during the period. Millennium Management LLC purchased a new stake in shares of Definitive Healthcare during the second quarter worth about $9,283,000. State Street Corp boosted its holdings in Definitive Healthcare by 29.4% in the 3rd quarter. State Street Corp now owns 1,399,729 shares of the company’s stock worth $6,257,000 after buying an additional 317,952 shares during the last quarter. 272 Capital LP raised its holdings in shares of Definitive Healthcare by 74.8% during the third quarter. 272 Capital LP now owns 1,114,080 shares of the company’s stock valued at $4,980,000 after acquiring an additional 476,766 shares during the last quarter. Finally, Granite Investment Partners LLC boosted its stake in shares of Definitive Healthcare by 22.5% in the second quarter. Granite Investment Partners LLC now owns 884,872 shares of the company’s stock worth $4,831,000 after acquiring an additional 162,432 shares during the last quarter. 98.67% of the stock is owned by institutional investors and hedge funds.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.